DK0839050T3 - Fremgangsmåde til at forstærke celleformidlede immunreaktioner - Google Patents

Fremgangsmåde til at forstærke celleformidlede immunreaktioner

Info

Publication number
DK0839050T3
DK0839050T3 DK93921698T DK93921698T DK0839050T3 DK 0839050 T3 DK0839050 T3 DK 0839050T3 DK 93921698 T DK93921698 T DK 93921698T DK 93921698 T DK93921698 T DK 93921698T DK 0839050 T3 DK0839050 T3 DK 0839050T3
Authority
DK
Denmark
Prior art keywords
mediated immune
immune responses
enhancing cell
enhancing
immunogen
Prior art date
Application number
DK93921698T
Other languages
Danish (da)
English (en)
Inventor
Balbir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0839050T3 publication Critical patent/DK0839050T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93921698T 1992-09-28 1993-09-21 Fremgangsmåde til at forstærke celleformidlede immunreaktioner DK0839050T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28
PCT/US1993/008900 WO1994007531A1 (en) 1992-09-28 1993-09-21 Method of enhancing cell mediated immune responses

Publications (1)

Publication Number Publication Date
DK0839050T3 true DK0839050T3 (da) 2004-10-25

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921698T DK0839050T3 (da) 1992-09-28 1993-09-21 Fremgangsmåde til at forstærke celleformidlede immunreaktioner

Country Status (11)

Country Link
EP (1) EP0839050B1 (OSRAM)
JP (1) JPH08502253A (OSRAM)
AT (1) ATE273022T1 (OSRAM)
AU (1) AU687750B2 (OSRAM)
CA (1) CA2145760A1 (OSRAM)
DE (1) DE69333588T2 (OSRAM)
DK (1) DK0839050T3 (OSRAM)
ES (1) ES2225825T3 (OSRAM)
MX (1) MX9306016A (OSRAM)
PT (1) PT839050E (OSRAM)
WO (1) WO1994007531A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6620300A (en) 1999-08-03 2001-02-19 Ohio State University, The Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
EA009901B1 (ru) * 2001-07-02 2008-04-28 Пфайзер Продактс Инк. Способ лечения или предупреждения заболевания или нарушения у животного, вызванного mycoplasma hyopneumoniae
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006138675A2 (en) 2005-06-15 2006-12-28 The Ohio State University Research Foundation Her-2 peptides
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
US20130064852A1 (en) 2010-05-11 2013-03-14 Intervet International B.V. Vaccine against mycoplasma, hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
EP0597852B2 (en) * 1990-05-29 2005-08-10 Wyeth Holdings Corporation Swine pneumonia vaccine and method for the preparation thereof
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
EP0839050A1 (en) 1998-05-06
WO1994007531A1 (en) 1994-04-14
MX9306016A (es) 1995-01-31
CA2145760A1 (en) 1994-04-14
DE69333588T2 (de) 2005-08-04
EP0839050A4 (OSRAM) 1998-05-06
AU4931293A (en) 1994-04-26
DE69333588D1 (de) 2004-09-16
ATE273022T1 (de) 2004-08-15
AU687750B2 (en) 1998-03-05
EP0839050B1 (en) 2004-08-11
JPH08502253A (ja) 1996-03-12
PT839050E (pt) 2004-11-30
ES2225825T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
DE3787663D1 (de) Impfstofformulierung.
EP0438803A3 (en) Vaccines against cancer and infectious diseases
DK0714444T3 (da) Dæmpning af en immundominant epitop i et antigen til anvendelse i plante-, dyre- og humanvacciner og immunbehandlinger
FI943171A0 (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
DE69536091D1 (de) Immunisierung durch Impfung von DNS Transkriptionseinheit
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
ES2152421T3 (es) Vacunas de conjugados polisacarido neumococcico-neumolisina recombinante para la inmunizacion contra las infecciones neumococcicas.
EE200100203A (et) Meetod immuunvastuse indutseerimiseks polüpeptiidse antigeeni vastu ja rakuga seotud polüpeptiidse antigeeni mahasurumiseks loomorganismil, selle meetodi kasutamine eesnäärme- ja rinnavähi raviks ning immunogeenne kompositsioon
NO950739D0 (no) Vaksiner mot gruppe C Neisseria Meningtidis
DK0839050T3 (da) Fremgangsmåde til at forstærke celleformidlede immunreaktioner
NO954318L (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
FI875015A0 (fi) Vaccin mot juverinflammation.
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
NZ331449A (en) Icom or iscom matrix vaccines for stimulating immune response in juvenile individuals
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
Zheng et al. Studies on the biological properties of a chemical vaccine prepared from antigenic fractions of Vibrio cholerae.
Dong et al. Preparation of various cholera vaccines and comparison of their immuno-effect.
Petrov et al. Synthetic immunogens prepared from enterobacteria. Communication I. Immunogenicity of Salmonella typhimurium O-polysaccharide conjugated with synthetic polyelectrolytes.
YU et al. Comparision of immunogenicity of vaccine produced by different rabies the strain
NO905619L (no) Identifikasjon av humane t-lymfocyttepitoper i patogener for vaksineutvikling.
ZA806606B (en) Specific antigen vaccine for tge in swine
RU2000102946A (ru) Способ вакцинотерапии онкозаболеваний
SE8605145D0 (sv) Anordning for uppvermning av dynor, stolsitsar och dylikt